GlassScriptPhysician profile
Rachel Lehrer
NPI 1629142559
$3,016.01
in general payments reported to CMS, 2019-2025
16 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $367 · 2022: $577 · 2023: $577 · 2024: $1,240 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,032 · Education: $40.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,031.81 |
| Education | $40.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $562.66 | 2021-2024 | Kcentra, Haegarda |
| Genzyme Corporation | $413.34 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $379.94 | 2022-2023 | Abilify Maintena |
| Astrazeneca Pharmaceuticals LP | $278.90 | 2021-2024 | Tezspire |
| Biocryst US Sales Co., LLC | $148.21 | 2023 | Orladeyo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $129.99 | 2025 | Caplyta |
| Dermavant Sciences, INC. | $125.66 | 2023 | Vtama |
| Novo Nordisk INC | $125.00 | 2025 | Wegovy |
| Paratek Pharmaceuticals, INC. | $125.00 | 2022 | |
| Abbvie INC. | $124.99 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $124.83 | 2022 | |
| Verrica Pharmaceuticals INC. | $120.68 | 2024 | Ycanth |
| Alkermes, INC. | $120.00 | 2024 | Lybalvi |
| Blueprint Medicines Corporation | $109.37 | 2024 | |
| Livanova USA, INC. | $95.63 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $31.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Lehrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.